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Abstract.  The c-erbA proto-oncogenes encode nuclear 
receptors for thyroid hormone (T3), a hormone inti- 
mately involved in mammalian  brain maturation.  To 
study thyroid hormone receptor (TR) action on neu- 
ronal cells in vitro, we expressed the chicken c-erbA/ 
TRot-1 as well as its oncogenic variant v-erbA in the 
adrenal medulla progenitor cell line PC12. In the ab- 
sence of T3, exogenous TRc~-I  inhibits NGF-induced 
neuronal differentiation and represses neuron-specific 
gene expression.  In contrast,  TRo~-I  allows normal 
differentiation and neuronal gene expression to occur 
in the presence of T3.  Finally,  TRc~-l-expressing cells 
become NGF-responsive for proliferation when T3 is 
absent, but NGF-dependent for survival in presence of 
T3.  A  similar differentiation induction by NGF plus T3 
was observed in a central nervous system-derived neu- 
ronal cell line (E  18) expressing exogenous TRot-1. 
Together with the finding that TRo~-I constitutively 
blocked dexamethasone-induced differentiation of PC12 
cells into the chromaffin pathway,  these results suggest 
that TRet-1 plays an important role in regulating com- 
mitment and maturation of neuronal progenitors. 
In contrast,  the v-erbA oncogene, a mutated,  onco- 
genic version of TRc~-I,  partially but constitutively in- 
hibited NGF-induced neuronal differentiation of PC12 
cells and potentiated dexamethasone-induced chromaflin 
differentiation,  giving rise to an aberrant "intedineage" 
cell phenotype. 
T  iaYaoio hormone (3,5,3'-triiodo-L-thyronine,  T3) t is 
an essential  regulator of physiological  and develop- 
mental processes in many cells and tissues.  In partic- 
ular, T3 plays a crucial role in late embryonic and neonatal 
development of the brain (for reviews see Hamburg,  1969; 
Morreale de Escobar et al., 1983; Legrand, 1984; Dussault 
and Ruel, 1987). Deprivation of thyroid hormone during rat 
brain development  causes diverse histological  and cellular 
abnormalities  such as changes in cell populations,  decreases 
in axon densities, dendrite formation and myelin deposition, 
and alterations  of cell migration,  leading to severe impair- 
ment of brain maturation  and function.  These alterations  are 
reversible  by T3 replacement until a certain age and might 
reflect aberrant or even absent differentiation of  both neurons 
and glial cells. In humans,  permanent mental deficiency due 
to insufficient T3 levels can only be avoided if replacement 
therapy is started early after birth.  In spite of the crucial im- 
portance of thyroid hormone for proper development of the 
central nervous system (CNS), very little is known about the 
molecular basis of thyroid hormone receptor action in neu- 
ronal ceils, most likely due to the complexity of the CNS and 
1. Abbreviations  used in this paper: CNS, central nervous system; DEX, 
dexamethasone; RA, retionic acid; RAR, retionic acid receptor; TH, tyro- 
sine hydroxylase; TR,  thyroid receptor; T3 triiodothyronine. 
the asynchronic patterns of development among their differ- 
ent parts and cell groups.  Only recently,  a few genes were 
found to be regulated at the pretranslational  level by thyroid 
hormone in vivo (Mufioz et al.,  1991). 
After identification  of the c-erbA proto-oncogene as the 
thyroid hormone receptor (TR) a-1 (Sap et al., 1986; Wein- 
berger et al.,  1986)  and discovery of two erbA  genes in 
higher  organisms  (or and  /3)  encoding a  whole family  of 
different receptor proteins,  several groups detected erbA ex- 
pression in the brain.  CNS neurons express the thyroid hor- 
mone receptor, and an increase in Trbinding  sites corre- 
lates with the period of neuroblast proliferation  in human 
fetuses (Bernal and Pekonen, 1984). TRot RNA has been de- 
tected very early (day 4) in the embryonal chicken brain,  in- 
creasing  progressively  thereafter  during  the  embryonai 
period (Forrest et al., 1990, 1991). TR/3 appears later in em- 
bryogenesis,  becoming predominant  in certain areas of both 
the CNS and the eye (Forrest et al., 1991). During rat brain 
maturation,  both ot and/3 receptors are expressed in a dis- 
tinct  fashion  characterized  by tight  temporal  and  spatial 
regulation  (Bradley  et al.,  1989;  Strait  et al.,  1991; Mell- 
strtm et al., 1991). In situ hybridization  studies indicate that 
TR mRNAs are present mainly in neurons from those brain 
areas known to be targets  of thyroid hormone,  such as the 
cerebral cortex, hippocampus,  cerebellum, and basal gan- 
glia. In particular,  cholinergic cells of the basal forebrain are 
© The Rockefeller University Press, 0021-9525/93/04/423/16 $2.00 
The Journal of Cell Biology, Volume 121, Number 2, April 1993 423-438  423 sensitive to thyroid hormones (Gould and Butcher, 1989). 
These cells also express maximum levels of the high affinity 
(gpl4(~  rk) NGF receptor (Holtzman et al.,  1992)  and thy- 
roid hormone and NGF were found to cooperate in the devel- 
opment of specific cholinergic  markers  in basal  ganglia 
(Patel et al., 1988) and other CNS areas (Clos and Legrand, 
1990).  These findings strongly suggest a key role of thyroid 
hormone receptors in neural tissue formation and matura- 
tion, probably involving cooperation with neurotrophins. 
We have addressed this question by studying the effects of 
%  on  neuronal  cells  differentiating in  culture.  Unfortu- 
nately, appropriate neuronal cell lines from the CNS capable 
of in vitro differentiation in response to neurotrophic factors 
are missing and primary cells obtained from brain do not 
grow in culture for extended time periods, hampering long- 
term studies. We therefore employed the PC12 cell line that 
has been extensively used as a model system for neuronal 
differentiation since its establishment from a rat pheochro- 
mocytoma (Greene and Tischler,  1976).  PC12  cells show 
characteristics of common precursor cells for sympathetic 
adrenergic neurons and neurosecretory epithelioid chromaf- 
fin cells. NGF induces PC12 cells to differentiate along the 
neuronal pathway,  whereas glucocorticoid hormones pro- 
mote their differentiation into chromaffin cells (Greene and 
Tischler, 1982;  Levi et al.,  1988).  Thus, PC12 differentia- 
tion  in  vitro  at  least  partially  mirrors  differentiation of 
respective neural crest-derived progenitor ceils in the rat 
adrenal medulla in vivo (Doupe et al.,  1985a,b; Anderson 
and Axel,  1986). 
Because of their origin from a tumor, it was not surprising 
that PC12 ceils behave aberrantly in several ways when com- 
pared to normal precursor cells in vivo. They continuously 
grow in the absence of neurotrophic factors, show an altered 
response to various exogenous stimuli and differentiate only 
partially into either neuronal or chromaffin cells. Also, they 
show no known response to thyroid hormone, a result also 
obtained in our own pilot experiments. This could be due to 
expression of low levels of c-erbA/TRot-1 together with high 
levels of c-erbA/TRot-2 RNA, which encodes a variant form 
of the receptor generated by differential splicing. TRot-2 is 
unable to bind hormone but efficiently  blocks transcriptional 
activation by the active c-erbA/TRot-1 form (Koenig et al., 
1989;  Lazar et al.,  1989;  Rentoumis et al.,  1990). 
For these reasons, we decided to stably express an exoge- 
nous TRot-1 gene in PC12 cells using suitable retroviral vec- 
tors (Mufioz et al.,  1990).  The rationale behind this study 
was to restore TRot-1 expression in a neuronal progenitor 
cell line that express only low levels of TRot-I, most likely 
as a consequence of the immortalization process, and then 
analyze neuronal differentiation in response to thyroid hor- 
mone and neurotrophic factors. We show in this paper that 
exogenous TRot-1 expressed at physiological levels regulates 
NGF-dependent differentiation and gene expression of PC12 
cells in a  T3  dependent fashion and constitutively blocks 
their entry into the chromaffin differentiation  pathway. In ad- 
dition, ligand-activated TRot-1 renders PC12 cells dependent 
on NGF  as  a  neurotrophic  factor.  In  contrast to  TRot-l, 
v-erbA, a mutated, oncogenic version of TRot-1 that seems 
to act as a constitutive repressor of genes regulated by c-erbA/ 
TRot-1 (Danun et al., 1989;  Sap et al., 1989; Disela et al., 
1991), constitutively inhibited both neuronal and chromaffin 
differentiation of PC12 cells. 
Materials and Methods 
Cells and Cell Cultures 
A clonal subline of rat PCI2 cells (referred to as 6c) was used throughout. 
This clone responded particularly well to differentiation induction by NGF 
in terms of neurite outgrowth on standard plastic dishes. 0Vrighton, C. W., 
and M. Busslinger, unpublished observations). PC12 6c cells were grown 
in DME supplemented with 10% horse serum, 5% FCS, and 1 mM gluta- 
mine (standard growth medium) (all from GIBCO, U.K.). Establishment 
and properties of the E 18 cell line derived by spontaneous immortalization 
from 17-d embryonic rat brain will be described elsewhere (Seliger, B., un- 
published observations). Cells were grown in Ham's F12  medium sup- 
plemented with 10%  FCS. 
Retrovirus Vectors and Generation 
of  erbA-overexpressing Cells 
The  recombinant retroviruses encoding the chicken c-erbA/TRct-1  and 
v-erbA genes used to infect PC12 6c cells have been already described (Mu- 
fioz et ai., 1990). Both are derived from the Moloney murine leukemia virus 
and encode the neomycin-resistant gene providing resistance to the antibi- 
otic G418.  For infection, 5  x  105 cells were plated in 60-ram dishes and 
incubated overnight with fibroblast-grown virus plus 8/~g/ml polybrene 
(Sigma Chem. Co., St. Louis, MO). Medium was then changed and selec- 
tion with 800 #g/ml (3418 (GIBCO BRL, Gaithersburg, MD) started 48 h 
after infection (Mufioz et al., 1990).  Six clones of resistant TR~l-infected 
cells could be expanded separately (cAI-cA6). cA4, the clone exhibiting the 
highest specific T3-specific  binding was used in all experiments. In con- 
trast, no individual v-erbA-infected  clones could be expanded. Therefore, 
a pool of G418  resistant, v-erbA-expressing clones was used. 
Infection of E  18 cells with TRot-1 was done exactly as described for 
PC12 6c. Ten TRot-l-expressing clones were obtained, one of which show- 
ing reproducible, high TRa-1 expression as determined by T3 binding (E 
18 cA9) was used in the experiments. 
Induction of Neural and Chroma~in Differentiation 
For induction of optimal neuronal differentiation, well suspended PC12 6c 
cells were seeded at 104 cells per cm  2 in standard growth medium. Murine 
7 S NGF (Sigma Chem. Co.) was added at a concentration of  50 ng/ml every 
2 d. Triiodothyronine (Sigma Chem. Co.) was added daily at a final concen- 
tration of 150 nM. Medium was changed partially or totally every 48 h. 
Chromaitin differentiation was induced by treatment with dexamethasone (5 
t~g/ml; Serva, Heidelberg) every 2 d or when the medium was changed. 
Embryonic CNS neuroblasts (E 18 cA9) were induced to differentiate by 
seeding them in serum-free Dulbecco's plus Ham's F12 (1:1) medium sup- 
plemented with the additions of N2 differentiation medium (Bottenstein 
and Sato, 1979).  NGF (50 ng/ml) was added every  2  d while T3 (150 nM) 
was added daily. 
pH]Thymidine Incorporation Assay 
Cells were seeded into 35-ram dishes in 2 nd standard growth medium at 
a density of 8  x  104 cells per dish and treated with NGF and/or 1"3 as de- 
scribed above.  Cell monolayers were labeled for 3.5 h with 1 /~Ci [6-3H] 
thymidine  (25  Ci/mmol:  Amersham  Intl.,  Buckinghamshire,  U.K.), 
washed twice with PBS, precipitated with 10% trichloroacetic acid for 10 
min, air-dried, and dissolved in 400 #1 of 0.1% NaOH and I% SDS. Radio- 
activity in 200/zl was estimated in a/3 counter. 
Mitomycin-C Treatment 
Cells were treated for 2 h with mitomycin-C (Sigma Chem. Co.) at a final 
concentration of  20/~g/ml. In pilot experiments, this concentration inhibited 
thymidine incorporation to <1% of respective controls without producing 
toxic effects. Monolayers were then washed three times with PBS, incubated 
for 30 rain with fresh medium, washed again,  and then trypsinized and 
reseeded for differentiation induction. Except for different mitomycin-C 
concentrations, the same procedure was previously used to demonstrate that 
differentiation occurs in absence of cell division in myoblasts (Falcone et 
al., 1984),  macrophages (Beug et al., 1987),  and erythroid cells (Beug et 
al.,  1992). 
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Detection of erbA protein (p46  c'erbA and p75SaS-v-e,~A)  by [3SS]methionine 
labeling and immunoprecipitation analysis was done as described earlier 
(Goldberg et al., 1988; Glinenr et al., 1990) using an anti-v-erbA antibody 
generously donated by Dr. J. Ghysdael. 
Hormone Binding Assay 
T3-specific binding assays in vivo were performed as previously described 
(Sap et al., 1986;  Mu5oz et al.,  1990).  Specific binding is defined as the 
ratio of iodinated T3 bound in absence and presence of a  1,000-fold  molar 
excess unlabeled T3. 
Detection of Neuronal and Chromaffin Differentiation 
Antigens by Immunofluorescence 
Fixed and permeabilized cells were analyzed by indirect immunofluores- 
cence using monoclonal antibodies to synaptophysin, tyrosine hydroxylase, 
glial fibrillary acidic protein (all from Boehringer Mannheim Corp., Ger- 
many), and N-CAM (Sigma Chem. Co.) according to standard procedures. 
Rabbit antiserum to mouse E-eadherin (uvomorulin; generously provided 
by Dr. R. Kemler) and mouse 46-kd cytokeratin (provided by Dr. E. Reich- 
mann)  were  used  similarly.  Basically,  ceils  were  fixed  with  3.7% 
paraformaldehyde plus 0.01% glutaraldehyde at 4°C for 15 rain, and then 
permeabilized with 0.1% NP-40 in medium for an additional 15 min at room 
temperature. Antibodies were used at the dilutions recommended by the 
manufacturers in a final volume of 50 t~l. After a  l-h incubation at room 
temperature, the plates were washed with PBS and stained with second anti- 
body (FITC-conjugated anti-mouse or anti-rabbit IgG, Amersham, diluted 
1:50) for 1.5 h. After staining, cells were washed three times with PBS, 
mounted in Mowiol (HOECHST), and viewed using a Zeiss Axiophot fluo- 
rescence microscope with epiillumination. 
RNA Preparation and Northern Analysis 
Total  RNA was  prepared using the guanidinium isothiocyanate-phenol- 
chloroform procedure (Chomczynski and Sacehl,  1987).  Purification of 
poly(A)  +  RNA was  done as described (Vermstrtm and Bishop,  1982). 
Northern blots were performed on Gene Screen membranes (New England 
Nuclear, Boston, MA) according to standard protocols (Maniatis et al., 
1982).  All probes were labeled by the random priming method (Feinberg 
and Vngelstein, 1983) using commercial kits (Pharmaeia LKB Bioteehnol- 
ogy Inc., Piscataway,  NJ). Source of probes: rat c-erbA/TR~l from Dr. 
R. M. Evans, rat TR-/3 from Dr. H. C. Towle, mouse c-jun,junB, andjunD 
and integrin-fll from Dr. R. Bravo, ratfra-1 from Dr. T. Curran, rat NGFI-A 
and NGFI-B from Dr. J. Milbrandt, v-fos from Dr. E. Wagner,  rat transin 
from Dr. R. Breathnaeh, mouse collagen cd (I) from Dr. Z. Q. Wang, rat 
SCG10 from Dr. D. J. Anderson, rat GAP-43 from Dr. M. C. Fishman, rat 
tyrosine hydroxylase from Dr. E. Ziff, rat chromogranin B from Drs. S. 
Forss-Petter/J.G. Sutcliffe,  mouse N-CAM  from Dr.  C.  Goridis,  mouse 
cytokeratin (endoB/K18) from Dr. M. Busslinger, human trk from Dr. M. 
Barbaeid, mouse trk from Dr.  L.  Parada,  rat LNGFR from Dr.  E.  M. 
Shooter, human RARer and mouse RARfl from Dr. H. Stunnenberg, and 
rat NF68 from Dr. E  Grosveld. Rat MASH-I and MASH-2 genes were 
cloned from poly (A)  + RNA prepared from dense cultures of PC12 6c cells 
by eDNA synthesis and PCR amplification using primers specific for the 
extremes of the published sequences (Johnson et al., 1990) obtained from 
the EMBL data bank.  The oligonueleotides used were 5'AATATAATG- 
AAGC~GCGTTTCTTCCCTTrTAAC  3' and  5'TATGA'IV_.AAGAA- 
TTCCATCC'IV_~'VICCAAAGTCCAT  3' for MASH-1 and 5'AATATAATG- 
AAGCTTGTCGAGGACGCATTAAGC  3'  and  5'TATGATCAAGAATTC- 
CAAGTCCTGGTTTC~  3' for MASH 2.  The amplified products 
were cloned into the HindIII and EcoRI sites of the pRK7 plasmid. Frag- 
ments covering the nonhomologous 3' ends were prepared as specific probes 
for both genes. A 308-bp PvulI fragment was prepared for MASH-1 and 
a 397-bp PstI-ScaI fragment for MASH-2. Hybridizations were carried out 
overnight at 65"C in 7% SDS, 500 mM sodium phosphate buffer, pH 7.2, 
and  1 mM EDTA according to Church and Gilbert (1984).  Filters were 
washed twice for 30 rain each in 1% SDS and 40 mM sodium phosphate 
buffer, pH 7.2, at 65"C. Before rehybridizing the nylon membranes with 
probes for other genes, the radioactive probe was stripped off  the membrane 
by placing it in a 750C  water bath for 5 min. 
Results 
Stable Expression of Exogenous erbA Genes 
in PC12 Cells 
To analyze the possible role of T3 and its receptor on PC12 
differentiation in vitro, we sought to stably express the avian 
c-erbA/TR~-I protein as well as its oncogenic variant, v-erbA, 
in these cells.  Cultures of a  clonal PC12  subline (6c,  see 
Materials and Methods) were infected with retroviruses ex- 
pressing  c-erbA/TRa-1 or v-erbA together with  the  neo  r 
gene as a selectable marker. Several neoresistant clones of 
c-erbA/TR,-I infected cells were obtained. In contrast, we 
only  succeeded to  expand a  pool of v-erbA-infected cell 
clones due to their poor clonal proliferation ability. 
The expression of the respective TR~-I and v-erbA pro- 
teins  was  monitored by  immunoprecipitation using  anti- 
erbA antisera,  c-erbA/TR~-I protein was just detectable, 
whereas v-erbA was expressed at high levels, comparable to 
those found in avian erythroleukemic cells (Fig.  1 A). Syn- 
thesis of active c-erbA/TRa-1 protein was confirmed by a 
hormone binding  assay  after incubation  with  ~25I-labeled 
%. Specific binding was one order of magnitude higher in 
c-erbA/TRcel-expressing cells than in uninfected or v-erbA- 
expressing cells (Fig. 1 B), and of the same order of magni- 
tude as that of rat GH1 pituitary cells containing a few thou- 
sand  active receptor molecules per  cell (Samuels  et al., 
1976,  1977). 
Endogenous Hormone Receptor Expression 
in Normal and erbA-expressing PC12 Cells 
Since several cell lines of neural origin express the thyroid 
hormone receptor variant TRot-2 in high excess over TRot-1 
(Mufioz, A., J. Bernal, and A. Rodriquez-Pefia, unpublished 
observations), we tested if this was also true for PC12.  As 
shown by Northern blot analyses,  normal PCI2  cells ex- 
pressed much higher levels of the TRot-2 form than of the 
TRot-1 and TRfl receptors (Fig. 1 C). In contrast, the retrovi- 
rus transduced exogenous c-erbA/TRot-1 and v-erbA genes 
were expressed at levels comparable to those of the endoge- 
nous TRtx-2 receptor. Thus, the nonresponsiveness of PC12 
cells to T3 may in fact be due to functional suppression of 
the low TRa-I levels by an excess of TRt~-2. 
To rule out that the c-erbA/TRct-1- and v-erbA-expressing 
PC12 sublines were altered in their expression of other im- 
portant receptors, the same blots were hybridized with cDNA 
probes  encoding  the  low  (gp80  ENG.) and  high  (gpl40  ~k) 
affinity NGF receptors as well as the retinoic acid receptors 
(RARs) ot and/~. All these receptors were expressed in the 
parental cells (distinct signal from 10 #g total RNA after 5-d 
exposure) and no changes in expression levels were detected 
in the sublines expressing exogenous erbA proteins (data not 
shown). 
Ligand-activated  TRa-1 Renders PC12 Cells 
NGF-dependent  for Proliferation and Survival 
Neurotrophic factors  such  as  NGF  are  considered to be 
necessary for survival of differentiating neuronal cells, in- 
cluding  primary  adrenal  medulla  sympathetic neurons  in 
culture. (Doupe et al.,  1985b; Anderson and Axel,  1986). 
In contrast, PC12 cells grow in the absence of NGF, and re- 
vert to an undifferentiated state if the factor is withdrawn af- 
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fected, TRot-1/c-erbA- and v-erbA-infected PC12 
cells were  labeled with  [35S]methionine  and  ly- 
sates from equal numbers of cells were immuno- 
precipitated with an antibody against v-erbA. The 
immunoprecipitates were analyzed on 10%  SDS- 
polyacrylamide gels  and  fluorographed.  Films 
were exposed for 6 d. Bands corresponding to the 
chicken p46  ¢-e~bA  and the viral p75  ~-v-e'~/'  are indi- 
cated by arrows. The faint p46  c'erbA band is also 
indicated by a solid triangle to distinguish it from 
two bands precipitated nonspecifically (open tri- 
angles). (N) preimmune serum;  (I) immune se- 
rum. (B) Uninfected and infected PC12 cells were 
analyzed for T3-specific  binding as described (Sap 
et al.,  1986;  Mufioz et al.,  1990),  in presence 
(+T3) or absence (-T3) of a  1,000-fold molar ex- 
cess (0.3 #M) of cold T3 as competitor. Rat pitui- 
tary GH1  cells expressing high levels of endog- 
enous T3  receptors were used as a  control.  (C) 
Analysis  ofTR RNA expression by Northern blots in uninfected, TRot-I- and v-erbA-infected PC12 cells. 10 #g of  total RNA were analyzed 
per lane. Exposure times: rat c-erbA/TR-ot, 6 d; rat c-erbA-TR/[3, 14 d. Mature endogenous TRot-1 RNA (lower band, 5 kb) and its precur- 
sor (upper band,  6.5 kb) are indicated with asterisks (*).  The band corresponding to the endogenous TRot-2 RNA (2.6 kb) is marked 
with an (x). It coincides with that of the viral subgenomic RNA encoded by the internal promoter. This RNA, as well as the large unspliced 
viral genomic RNAs (indicated by arrows) crosshybridize with both rat c-erbA probes, ot and/3.  Hybridization with the/3 probe gives 
two very weak signals corresponding to the precursor (6.5 kb, arrowhead) and mature (4 kb) RNAs. 
ter induction of differentiation. To determine whether TRc~-I 
expression would affect PC12 cells responsiveness to NGF, 
we first studied the effects of T3, NGF, or their combination 
on the capacity of uninfected and erbA expressing cells to 
proliferate and to synthesize DNA. 
As shown in Fig. 2,  treatment with NGF alone or NGF 
plus  T3  did  not  grossly  affect proliferation of uninfected 
cells (panel A,  left).  In cells expressing exogenous  TRot-1 
however, T3 and NGF had clear but opposite effects on sur- 
vival and proliferation. NGF alone led to a drastic increase 
Figure 2.  Effects  of T3  and 
NGF on the proliferation and 
survival  of  uninfected, TRot-l- 
and  v-erbA-PC12  cells.  (A) 
Proliferation capacity of the 
three cell types was analyzed 
after  5  d  of treatment  with 
NGF,  T3,  or both hormones 
(NGF  +  T3)  by  measuring 
the  incorporation of tritiated 
thymidine into trichloroacetic 
acid-precipitable  material (see 
Materials and Methods). Hori- 
zontal bar indicates the incor- 
poration level (100%)  of the 
corresponding untreated con- 
trol  cells.  (B)  TRot-l-  and 
v-erbA-PC12 cells were treated 
for 7 d with NGF plus T3, and 
then incubated with T3 alone 
(circles),  NGF  alone  (trian- 
gles), or no hormone (inverted 
triangles). Surviving cells were 
counted 2 and 3 d later after 
extensive washing of the mono- 
layers.  Hundred percent val- 
ues  correspond to cell num- 
bers obtained with each cell 
type after the initial 7-d NGF 
plus T3 treatment. (C) TRa- 
1-PC12 cells were incubated with mitomycin C (Mit. C, see Materials and Methods) or left untreated (Control). They were then incubated 
with NGF for 6 d (+ NGF) or with NGF-free medium (no NGF). Phase micrographs of these cells (middle and lower panels) as well 
as of respective uninfected PC12  cells induced to differentiate with NGF are shown (upper panels).  Bar, 50 #m. 
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was reflected by a 30 % increase in cell number after 5 d (not 
shown).  T3 had an opposite effect: DNA synthesis ceased, 
and cells no longer divided and degenerated progressively. 
None of these effects were observed upon combined treat- 
ment with NGF and T3. 
These observations suggested that ligand-activated TRot-1 
indeed  rendered  PC12  cells  dependent  for  survival  and 
proliferation on neurotrophic factors like NGE To confirm 
this,  cells were pretreated for one week with NGF  +  T3, 
and then cultured in medium containing no additions of ei- 
ther T3 or NGF separately. When switched to T3 containing 
medium, more than 80% of TRot-1 cells degenerated within 
3 d (Fig. 2 B), while they survived as differentiated cells in 
control  cultures  containing  NGF  +  T3  (see  below).  A 
significant  proportion  of TRot-1 cells  died  even  in  plain 
medium and only NGF was able to prevent cell death. V-erbA- 
expressing cells were completely refractory to any of these 
treatments (Fig. 2 B), while normal, uninfected cells showed 
weak, intermediate responses (data not shown). Whether or 
not the cells died by programmed cell death (apoptosis) after 
removal of NGF as shown to take place during normal CNS 
development in vivo (for review see Oppenheim,  1991) is 
still under investigation. 
C-erbA/TRa4 and v-erbA Affect NGF-induced 
Neuronal Differentiation in PC12 cells 
To determine whether TRot-1 or v-erbA expression affects 
the ability of PC12 cells to differentiate into neurons in re- 
sponse to NGF, uninfected cells, and cells expressing c-erbA/ 
TRot-1  or v-erbA were treated with NGF,  T3, or both for 
5-7 d.  The extent of neuronal differentiation was estimated 
by monitoring neurite outgrowth and expression of two nell- 
ronal markers, synaptophysin and N-CAM (Prentice et al., 
1987; Mann et al., 1989), on neurites and cell bodies by im- 
munofluorescence. As controls, cells were stained with anti- 
bodies to tyrosine hydroxylase (TH), an enzyme which is 
downregulated by NGF but induced by dexamethasone dur- 
ing chromaffin differentiation (Lewis et al.,  1983; Leonard 
et al., 1987; Stein et al., 1988b), and to glial fibrillary acidic 
protein, an astrocyte marker. 
As expected, NGF treatment of uninfected cells induced 
cell flattening followed by appearance and progressive elon- 
gation of neurites and rounding of cell bodies (Fig. 3). The 
neurites expressed high levels of synaptophysin and lower 
levels of N-CAM, while TH expression decreased (from 55 
to  16%  fluorescence positive cells; Fig.  3).  As mentioned 
above, T3 alone had no major effects on normal PC12 cells 
and  did not detectably alter NGF-induced differentiation, 
when applied together with NGF (data not shown). 
In contrast, expression of exogenous TRoe-1 strongly ar- 
rested NGF-induced differentiation. When treated for 6  d 
with NGF alone, the cells developed only short processes 
that failed to elongate even after prolonged NGF application 
(Fig. 4). TRot-l-cells also failed to upregulate synaptophysin 
and N-CAM expression in response to NGF (Fig. 4 and data 
not shown).  TH content was low already in the uninduced 
stage  (20%  positive cells)  and  was  further reduced after 
NGF (2.5%  positive cells, not shown). 
Interestingly, the differentiation  block could be completely 
reversed by addition of T3 together with NGE After 6 d of 
exposure to both agents,  a high proportion of TRot-1 cells 
produced long processes expressing synaptophysin and N-CAM 
at similar or even higher levels as uninfected cells in the pres- 
ence of NGF alone (compare Figs. 3 and 4, data not shown). 
In the absence of NGF,  T3 induced progressive cell death 
which affected 30-80 % of  the population after 5 d depending 
Figure 3.  NGF-induced neu- 
ronal differentiation of clonal 
PC12 6c ceils. Phase micro- 
graphs of uninfected PC12 6c 
cells treated with NGF for 7 d 
(+  NGF)  see  Materials  and 
Methods)  or  left  untreated 
(Control) are shown (left  pan- 
els).  Parallel  cultures  were 
stained with antibodies against 
synaptophysin,  tyrosine  hy- 
droxylase, N-CAM, and glial 
fibdllary acidic protein (GFAP, 
negative control), and photo- 
graphed  (see  Materials  and 
Methods). Bar, 50/zm. 
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shown). 
Cells expressing v-erbA showed a distinctly different re- 
sponse.  They  were  arrested  in  neuronal  differentiation 
regardless of whether the cells were treated with NGF alone 
or  in  combination  with  T3  (Fig.  4).  In  both  cases,  they 
formed only short processes that expressed no synaptophysin 
with NGF alone, while some expression was seen at the neu- 
rite tips with NGF  +  T3 (Fig. 4).  This latter result agrees 
with the assumed role of v-erbA as a constitutive repressor 
of TR-regulated genes (Sap et al., 1989; Damm et al., 1989). 
T3 alone had no effect on these cells. 
Since  cells expressing TRa-1  were induced  by NGF to 
grow  at  an  increased  rate  we  had  to  rule  out  that  their 
differentiation  arrest  was  a  consequence  of an  increased 
proliferation and cell density. To rule out this possibility cell 
differentiation was studied after inhibition of cell prolifera- 
tion with mitomycin-C. Uninfected PC12 cells differentiated 
normally  in  response to  NGF  in  presence  or  absence  of 
mitomycin-C (Fig.  2  C,  upper panels).  In  contrast,  both 
mitomycin-treated  and  control  TRc~-I  cells  formed  only 
short processes in response to NGF (Fig. 2 C). This suggests 
that the stimulation of proliferation and the differentiation ar- 
rest  caused by  TRu-1  in  NGF-treated PC12  cells  are un- 
related phenomena. 
Retinoic Acid Receptors Do Not Play 
a Major Role in TRu4 Regulated Neuronal 
Differentiation of PC12 Cells 
Since PC12 cells express retinoic acid receptors (RARol and 
RAR/~) and cooperation of TRs and RARs is thought to be 
crucial for thyroid hormone action in several systems (Hud- 
son et al.,  1990;  Schroeder et al.,  1992b),  we determined 
whether retinoic acid (RA) would affect Trdependent regu- 
lation  of  differentiation  in  normal  and  TRol-l-expressing 
PC12 cells. In either cell type, RA did not grossly affect neu- 
ronal differentiation induced by NGF or NGF  +  T3. Also, 
RA did not alter the T3-induced NGF dependence of TRot-1 
cells.  However,  if used  alone,  RA  seemed to  induce  cell 
rounding and formation of aggregates similar to those seen 
during  the  initial  stages  of dexamethasone-induced  chro- 
Figure 4.  Arrest  of NGF-in- 
duced neuronal differentiation 
by TRa-I and v-erbA. Phase 
micrographs  of  TRot-1 and 
v-erbA-expressing PCI2 cells 
treated  with NGE NGF plus 
T3 (7 d) or T3 alone (5 d), or 
left  untreated  (Control) are 
shown. Middle panels (TRc~-I) 
and  insets  to  right  panels 
(v-erbA) show the correspond- 
ing immunofluorescence anal- 
ysis using synaptophysin anti- 
body  (see  Materials  and 
Methods).  Bar, 50 #m. 
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was not affected by the presence or absence of exogenous 
TRot-I, suggesting that the RARs do not play a major role in 
the regulation of neuronal differentiation by TRot-1. 
TRa4 Does Not Affect the Induction 
of  Early Genes by NGF 
Several dozen genes are known to be induced  by NGF in 
PC12 cells (for a review see Halegoua et al.,  1991).  These 
genes can be distributed in two groups: early response genes 
whose induction begin a few minutes after NGF addition and 
peak one or a few hours later, and late response genes which 
are induced with slower kinetics and reach their maximum 
level of expression two, four, or more days after continuous 
NGF treatment. 
First, we analyzed possible effects of TRot-1 on the expres- 
sion of NGF-inducible early  genes,  such as c-jun, jun-B, 
jun-D, c-fos, fra-1, NGFI-A (Krox 24,  egr-1, zif1268), and 
NGFI-B (nur/77, N10) which have been reported to be in- 
duced by NGF to a variable extent (Greenberg et al.,  1985; 
Kruijer et al.,  1985; Morgan and Curran,  1986; Milbrandt, 
1987,  1988;  Bartel et al.,  1989;  Szebertnyi et al.,  1990). 
Thefra-1 gene was particularly interesting, since its constitu- 
tive expression apparently blocks induction of many of the 
other early genes (Ito et al.,  1990).  Uninfected and TRot-l- 
expressing cells were treated for 1 h  with NGF, T3 or both 
hormones,  and  subjected to Northern blot analysis, using 
poly(A)  + RNA (Fig.  5). 
NGF caused a  similar transient upregulation of all these 
genes in uninfected and TRot-I-expressing cells with strong 
increments of mRNA levels after  1 h,  and much less after 
24 h. Furthermore, T3 neither superinduced nor suppressed 
the induction of any of these genes by NGF in either cell type 
Figure 5. TRot-1 does not af- 
fect  expression  of  NGF-induced 
early genes. Northern blot anal- 
yses  for expression  of NGF- 
induced early genes were per- 
formed with uninfected (PC12) 
and  TRot-l-expressing  PC12 
cells (PC12 + TRa-1) treated 
for 1 (1 h) or 24 h (24 h) with 
NGF, T3 or both (NGF + T3), 
or left untreated (-). Expres- 
sion of  cyclophilin mRNA was 
used as control.  2.5  /zg poly 
(A)  + RNA  were  loaded  per 
lane.  Exposure  times: fra-l, 
3 d; c-fos, 3 d; c-jun, 1 d;jun 
B; 16h;jun D, 16h; NGFI-A, 
4 h; NGFI-B, 16 h; and Cyclo- 
philin, 16 h. 
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for ornithine decarboxylase (not shown). These results show 
that TRot-1 does not interfere at all with NGF-regulated early 
gene expression, indicating that NGF is able to induce all its 
normal intracellular signals in TR~l-expressing PC12 cells. 
TRa-I Causes Hormone-dependent  Repression 
of NGF-induced Late Genes 
Having ruled out that TRot-1 affects NGF-dependent signal 
transduction,  we  checked  the  alternative  hypothesis  that 
TRa,-1 might block the expression of neuronal-specific genes 
in absence of ligand, but allow or even enhance their NGF- 
regulated expression in presence of T3. Such a result would 
be expected from a  similar behavior of TRt~-I in transient 
transfection experiments (Damm et al.,  1989;  Sap et al., 
•989)  as well as in avian erythroblasts (Zenke et al.,  1988, 
1990).  Consequently,  cells were treated with NGF alone, 
NGF  +  T3, or left untreated,  and tested for late gene ex- 
pression in Northern blots. 
TRa-1  strongly affected expression  of a  large  series  of 
NGF-inducible late genes (Fig. 6). This group consisted of 
Figure 6.  T3-dependent regu- 
lation  of  NGFqnduced  late 
genes by TR~x-1. Expression 
analysis of NGF-induced late 
genes (upper pane/s), MASH-I 
(middle panels),  and  of two 
chromaflin marker  genes (low- 
er panels)  by  Northern  blot 
hybridization  vats performed 
in  uninfected,  TRa-1-  and 
v-erbA-expressing PC12 cells 
after treatment with NGF, NGF 
+  T3, or no hormone (-) for 
1 and  24  h  as weU as  for 3 
(3 d) or 6 d (6 d) as described 
in the legend to Fig. 5. l0/~g of 
total RNA vcere  loaded  per lane. 
Exposure  times: MASH-I,  1 
a_nd 24 h, 20d; 6d, 14d; Tmn- 
sin,  3  d;  SCGIO, 3  d;  NF68, 
6 d; Integrin/3, 6 d; Collagen 
cd(I), 4 d; N-CAM, 6 d; GAP- 
43, 6 d; TH, 16 h; (~romogra- 
n/n B, 7 h; and Cyc~philin, 2 d. 
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and GAP-43;  Prentice et al.,  1987; Stein et al.,  1988a,b; 
Lindenbaum et al., 1988; Federoffet al., 1988), the protease 
transin probably involved in neurite outgrowth (Machida et 
al., 1989) and extracellular matrix proteins and their recep- 
tors (collagen-otl  [1], integrin-fll; Mann et al.,  1989;  Van 
Hoof et al.,  1989; Costello et al.,  1990).  In absence of T3, 
TRot-1 efficiently  repressed upregulation of  all these genes by 
NGF. Exposure of the cells to NGF plus T3 stimulated ex- 
pression of all genes to similar or even higher levels than ob- 
served in normal PC12 cells induced to differentiate by NGF 
alone or by NGF +  T3. In addition, several of these genes 
(e.g., SCG-10, integrin-fll) appeared to be repressed in PC12 
cells expressing unliganded TRot-1 (Fig. 6). A similar pat- 
tern  was  found for two additional genes  (peripherin  and 
MAP-2) that were only weakly induced by NGF (data not 
shown). Thus, TRot-1 regulates neuronal gene expression in 
a  fashion faithfully reflecting its effect on morphological 
differentiation. 
TRt~4 Does Not Affect NGF-induced Repression 
of the Early Neuroblast Marker MASH-1 
The MASH-1  and MASH-2 genes, rat homologues of the 
Drosophila achaete-scute genes probably involved in neu- 
ronal development, were recently isolated as candidates for 
neuronal "master" genes (Johnson et al., 1990).  Later work 
suggested that the MASH-1 gene may be a marker for early 
neuronal progenitors and that NGF causes the loss of this 
early marker in PC12 cells (Lo et al., 1991). Because of  their 
possible significance for neuronal differentiation, it was of 
interest to study if MASH gene expression was regulated by 
TRot-1. 
Northern blot analysis revealed no detectable expression 
of the MASH-2 gene (not shown). MASH-1  mRNA levels 
remained unchanged in normal and TRot-1 cells after  1 h 
treatment with NGF or NGF  +  T3 (Fig. 6). Treatment for 
24 or 144 h with these agents caused a significant decrease 
in MASH-1 mRNA levels in both cell types, although down- 
regulation of MASH-1  message  by  NGF  alone  occurred 
more slowly in the TRot-l-expressing  cells. These findings 
agree with those from Lo et al. (1991) and confirm our results 
on the early NGF-induced genes, suggesting that TRot-1 does 
not simply block NGF action, but causes a  late arrest in 
PC12  differentiation via an NGF-independent pathway. 
TRot4 Prevents Entry of  PC12 Cells into the 
CbromaJfin Differentiation Pathway 
Having shown that TRot-1 regulated neuronal differentiation 
and gene expression in a  hormone-dependent fashion, we 
next investigated whether TRot-1 might affect the alternative 
differentiation pathway open to PC12 cells, i,e., chromaffin 
differentiation induced by dexamethasone (DEX). DEX was 
reported to cause morphological changes and expression of 
some chromaftin markers in PC12 cells (Greene and Tisch- 
ler, 1982) and to antagonize the action of NGF at the molec- 
ular level (Leonard et al.,  1987; Stein et al.,  1988b). 
After prolonged DEX treatment (20 d), uninfected PC12 
cells adopted a rounded or polygonal shape, strongly adher- 
ing to each other, and formed cords and clumps which even- 
tually fused into compacted epithelioid islands. This pheno- 
type was  not altered by the presence  of T3.  In contrast, 
DEX-treated TRot-1 cells showed a delay in the formation of 
cell clumps which failed to develop into dense, compact is- 
lands. In presence of T3, the cultures contained even more 
individual cells and few loose clumps, cells displaying a po- 
lygonal shape and short neurite-like spikes (data not shown). 
These pilot studies raised the possibility that TRot-1 in- 
hibited  DEX-induced  differentiation of  PC12  ceils  into 
epithelioid, chromaffin-like cells. This was confirmed by the 
pattern of expression of epithelial markers such as cytokera- 
tins  and  E-cadherin  (uvomorulin).  Strong  expression  of 
cytokeratins and weak, but distinct expression of  membrane- 
bound uvomorulin was seen in the epithelioid islands ob- 
tained from DEX-treated  uninfected cells.  Expression of 
both markers was essentially missing in the loose groups of 
TRot-l-expressing  cells subjected to the same treatment (data 
not shown, see below). We also studied the expression of the 
chromaffin marker TH. As expected, TH was strongly up- 
regulated by DEX in uninfected cells (55->98%  strongly 
positive cells, Fig. 7 A). In contrast, TRot-1 cells expressed 
only low levels of TH (<10% weakly positive cells), which 
were only weakly upregulated by DEX (<30% positive cells; 
Fig. 7 A). 
Differentiation  of  uninfected  PC12  cells  induced  by 
prolonged DEX treatment was irreversible (Fig. 7 B). Even 
after DEX removal and subsequent treatment with NGF or 
NGF +  T3 most cells remained forming epithelioid islands 
expressing chromaffin markers (cytokeratin and uvomoru- 
lin).  In contrast,  TRot-1 expression prevented irreversible 
chromaffin differentiation. TRot-1 cells treated sequentially 
with  DEX  and  NGF  appeared  immature with  numerous 
short neurites and failed to express uvomorulin or cytokera- 
tin (except for a low percentage of cytokeratin-positive cells; 
Fig.  7  B).  As expected,  if T3  was administered together 
with NGF the cells differentiated into neurons. These results 
indicate that TRot-l-expressing  PC12  ceils respond abnor- 
mally  to  DEX  induction.  Instead  of differentiating into 
chromaffin cells, they retain an undifferentiated phenotype 
and remain inducible by NGF +  T3 to form neurons. Thus 
TRot-1 constitutively prevents entry of PC12  ceils into the 
chromaffin pathway,  raising the possibility that TRot-1 ex- 
pression  commits  the  cells  to  the  neuronal  pathway  of 
differentiation. 
The effect of TRot-1 in blocking entry into the chromaffin 
pathway was also confirmed by studying the expression of 
two genes,  TH  and chromogranin B  which although ex- 
pressed in neurons are induced by DEX during chromaffin 
differentiation of PC12 cells (Lewis et al., 1983; Leonard et 
al., 1987; Stein et al., 1988b).  Both basal and DEX-induced 
expression of TH was blocked in cells expressing TRot-1 
(Figs.  6 and 8).  Neither NGF nor T3 or both could release 
the  suppression  of TH  mRNA  levels  (Fig.  6).  A  much 
weaker suppressive effect of TRot-1 was observed for the 
chromogranin B and cytokeratin genes. 
V-erbA Constitutively Induces 
an Aberrant Phenotype Combining Neuronal 
and Chromaffin Characteristics 
The v-erbA oncogene acts as a constitutive repressor of red 
cell differentiation and erythrocyte gene expression in avian 
erythroblasts (Zenke et al., 1988, 1990; Disela et al., 1991). 
It also interferes with transactivation of synthetic TR/RAR 
Mufioz et al. erbA Regulates PCI2 Cell Differentiation  431 Figure 7. Effects of  TRc~-I and v-erbA  on dexamethasone-induced chromaflin differentiation in PC12 cells. (.4) Immunotluorescence analysis 
of tyrosine hydroxylase protein expression in uninfected, TRc~-I-, and v-erbA PCI2 cells treated with dexamethasone for 2 wk (DEX) or 
left untreated (Control.) Bar, 50 #m. (B) (Upper  group ofpanels; Morphology) Uninfected PC12 cells and TRct-I-PCI2 cells were treated 
for 20 d with dexamethasone. They were then washed and incubated for an additional 7 d with NGF (Dex~NGF) or NGF +  T3 (DEX 
~NGF +  T3). Phase micrographs of representative areas are shown. Note presence of dense epithelioid islands surrounded by neuron- 
like cells in the normal PC12 cells. Bar, 50 #m. (Lower  group of  panels) Immunofluorescence analysis on parallel dishes to those photo- 
graphed  in the upper panels,  using uvomorulin (E-cadherin) and cytokeratin antibodies,  is shown. 
response elements by RARot (Sharif and Pfivalsky, 1991) and 
has been claimed to prevent inhibition of fibroblast prolifera- 
tion by RA (Desbois et al.,  1991).  We therefore studied in 
more detail how v-erbA affected differentiation and gene ex- 
pression in PC12 cells. 
As already described above, v-erbA  expression caused a 
constitutive,  partial  inhibition  of  NGF-induced  neuronal 
differentiation, regardless of the presence or absence of thy- 
roid hormone (Fig. 3). In contrast to TRot-1 cells, DNA syn- 
thesis and cell proliferation were not affected by NGF or T3 
treatment in v-erbA cells (Fig. 4 A). Most strikingly, T3 did 
not induce an NGF dependence for cell survival, and even 
the  weak  cytopathic  effect induced  by  T3  alone  in  unin- 
fected cells was completely absent in v-erbA expressing cells 
(Fig. 4 B). This protective effect of v-erbA may well be due 
to suppression of endogenous c-erbA  action. 
Similarly to TRot-I, v-erbA did not affect the induction of 
early genes by NGF (Fig. 5). In contrast to TRot-I, however, 
v-erbA did not cause a repression of most late NGF inducible 
genes studied (Fig. 6) and was not able to prevent their in- 
duction by NGE As expected from the inability of the v-erbA 
protein to bind and respond to hormone (Sap et al.,  1986; 
Mufioz et al.,  1988,  1990,  see Fig.  1), T3 did not alter ex- 
pression levels of most NGF-inducible genes in v-erbA ceils. 
The transin (stromelysin) gene was an interesting excep- 
tion. Induction of this gene by NGF was strongly inhibited 
in v-erbA ceils as compared to normal PC12 cells (Fig. 6). 
This repression persisted even after incubation with NGF + 
T3, leading to much lower levels of transin mRNA than ob- 
tained in normal or c-erbA cells treated similarly. It seems 
possible, therefore, that v-erbA is able to constitutively re- 
press a subset of NGF-inducible genes, in line with its ability 
to partially inhibit neuronal differentiation. 
Finally, v-erbA had an unexpected effect on DEX-induced 
chromatfin differentiation and gene expression. Treatment of 
v-erbA cells with DEX caused their flattening and aggrega- 
tion into small groups, but epithelioid islands were not ob- 
served even after prolonged DEX treatment. In line with this 
finding, no E-cadherin could be detected on the cell mem- 
branes by immunofluorescence (data not shown).  However, 
the cells expressed constitutively elevated levels of cytokera- 
tin and TH. Even in untreated cells, staining with TH and 
cytokeratin antibodies was very strong (Fig. 7 A and data not 
shown) and even increased after DEX treatment (Fig. 7 A). 
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marlin and epithelial  genes in 
erbA-expressing  PC12  cells. 
Northern  blot  analyses  of 
tyrosine  hydroxylase  (TH), 
chromogranin  B,  and  cyto- 
keratin mRNA expression was 
performed  using  uninfected, 
TRcz-1,  and  v-erbA-PC12 
cells.  Cells  were treated  with 
DEX, DEX +  T3 for 6 (6 d) 
or 14 d (14 d), or left untreated 
(-).  As controls, cyclophilin 
expression  was  determined. 
10  #g  of  total  RNA  were 
loaded  per  lane.  Exposure 
times: TH, 7 h; Chromogranin 
B, 4 h; 46 kd Cytokemtin, 3 d; 
and Cyclophilin, 2 d. 
The results obtained for chromaffin marker gene expres- 
sion were in line with these observations. Untreated or NGF- 
treated v-erbA cells expressed significantly higher levels of 
TH,  chromogranin  B,  and  cytokeratin  messages  than  the 
respective uninfected ceils (Fig. 8). However, DEX was still 
able to further induce these genes to similar levels in both 
normal and v-erbA-expressing ceils. This suggests that v-erbA 
constitutively  upregulates  chromaffin marker  gene expres- 
sion, but does not prevent their regulation by DEX (Fig. 8). 
A  summary of the effects of c-erbA/TRot-1  and v-erbA on 
PC12 cell differentiation and survival is represented in Fig. 9. 
To  rule  out the  trivial  possibility  that our v-erbA-PC12 
cells  fail  to  differentiate  because  of irreversible  cell  line 
progression  changes,  we tried  to  induce  differentiation  in 
Figure 9. Schematic representation  of how TRot-1 
and v-erbA regulate  PC12 cell differentiation  into 
neurons and chromaffin cells.  (Upper panels)  In 
both presence and absence of '1"3, normal PC12 
cells differentiate into neurons or chromaflin cells 
upon NGF or dexamethasone  treatment,  respec- 
tively. They are independent  of NGF for growth 
and  survival  in the absence of Ta and exhibit  a 
weak  or  absem  NGF dependence  (+/-)  in  its 
presence.  (Middle panels)  TRot-l-expressing 
PCl2 cells are partially blocked (black bar across 
arrow) in their capacity to differentiate  into either 
neurons or chromaflin cells  in the absence of T3. 
Upon T~ addition,  these cells  respond normally 
to NGF, becoming neurons.  In contrast, differenti- 
ation into more mature chromaflin  cells  remains 
blocked in the presence of T3.  TRot-1  cells  are 
strongly dependent (+++) on NGF for survival 
when 1"3 is present.  (l_znverpanels) V-erbA-PC12 
cells  are partially blocked for NGF-induced neu- 
ronal differentiation  regardless  of the presence or 
absence of 1"3. They exhibit  a probably aberrant 
phenotype  combining  neuronal  and  chromaflin 
markers  (indicated  by altered  cell  shape)  in the 
presence of dexamethasone.  They do not respond 
at all to T3 (-). 
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shown to induce part but not all of the NGF-induced pheno- 
typic and gene expression changes in PC12 cells, most likely 
via  pathway(s)  independent  of those  important  for NGF 
action (see Halegoua et al.,  1991).  Indeed, NGF plus di- 
butyryl-cAMP  (0.1 mM)  induced  distinct  morphological 
differentiation characterized by typical long neurites in both 
TRct-1- and v-erbA-expressing PC12 cells. In line with pub- 
lished work (Gunning et al.,  1981),  dibutyryl cyclic AMP 
alone at high concentrations (1  mM)  also induced partial 
differentiation in both cell types. Thus, the v-erbA-induced 
differentiation arrest cannot be due to mutational changes in 
our cell lines. 
Spontaneously Immortalized Rat Brain Neuroblasts 
Differentiate in Response to T~ and NGF 
after Introduction of  an Exogenous TR~-I Gene 
Since TRot-1 has no reported function in differentiation of 
normal  adrenal  medulla  progenitors,  the  possibility  re- 
mained that our results employing the PC12 cell system rep- 
resented the aberrant behavior of a tumor cell line, mimick- 
ing  normal  differentiation processes as  a  consequence of 
artificial experimental treatments.  We therefore sought to 
demonstrate an effect of TRu-1 in neuroblasts derived from 
the CNS, where the involvement of thyroid hormone recep- 
tors in neuronal maturation is amply documented (see in- 
troduction). Consequently, we introduced the avian TRot-1 
into the E 18 cell line, which has been obtained by spontane- 
ous  immortalization from cultures  of  17-d rat embryonic 
brain (Seliger, B., unpublished observations). E 18 cells rep- 
resent primitive  neuroblasts  that  express  NF  68  and  the 
primitive  neuronal  marker  nestin,  but  lack  the  astrocyte 
marker, glial flbrillary acidic protein. After partial differen- 
tiation induction with dibutyryl-cAMP, the cells express fur- 
ther neuronal markers such as NF 145, NF 220, and neuron- 
specific enolase. Similarly to PC12 ceils, the El8 cells ex- 
pressed only low levels of TRt~-I together with high levels 
of TRet-2 (data not shown). 
To  test  the  ability  of TRt~-I  expressing  E  18  cells  to 
differentiate in response to NGF, T3 or both, we used an E 
18 clone infected with the TRt~-I retrovirus as described for 
PC12 cells. This clone expressed TRcM at similar levels as 
the TRot-1 PC12 clone cA4 (data not shown). As shown in 
Fig.  10, TRot-1 E  18 cells failed to differentiate in response 
to NGF alone, a property shared with uninfected E 18 ceils. 
Also, NGF seemed not to influence E  18 cell proliferation. 
Upon T3 addition, cells became less adherent and partially 
disintegrated (Fig.  10, T3) mirroring the cell killing effect 
observed in PC12 cells. In presence of both NGF and T3, 
however, essentially all cells underwent massive neuronal 
differentiation characterized by outgrowth of long neurites 
Figure 10.  T3  plus  NGF in- 
duce differentiation in TRc~-I 
expressing  E  18  neuroblasts 
derived  from  embryonic  rat 
brain. Phase micrographs are 
shown from E  18  cA9 cells 
cultivated in serum-free differ- 
entiation medium for 6 d  in 
absence (Control) or presence 
of T3, NGF, or both (NGF + 
/'3). Note effective  differentia- 
tion into neuron-like  cells upon 
treatment with both NGF and 
T3 (panel NGF +  T3) Inset: 
Some of the neuron-like cells 
obtained with NGF + T3 in a 
separate experiment at higher 
magnification. Note also cell 
disintegration (refractile small 
bodies) in the Ta-treated cul- 
tures. Bar, 50/xm. Inset: bar, 
20/~m. 
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expression in CNS derived neuroblasts conferred respon- 
siveness to T3 in a fashion very similar to that observed in 
TRc~-I expressing PC12  cells. 
Discussion 
Effect of TRa4 on PC12 Cell Differentiation: 
Evidence for a NGF-independent,  Permissive 
Function in Neuronal Differentiation 
In this study, we provide the first direct evidence that TRot-1 
controls neuronal differentiation and expression of neuron- 
specific genes in PC12  cells. Both NGF-induced neuronal 
differentiation and expression of late genes are arrested by 
TRtx-1 in the absence of its ligand, T3, while the block is 
released in the presence of the hormone, leading to efficient 
cell maturation (see Fig. 9  for a model). These effects of 
TRot-1 are  strikingly  similar to  those observed  in  avian 
erythroblasts where TRot-1 regulates erythroid differentia- 
tion  and  erythrocyte gene  expression  in  a  T3-dependent 
fashion (Zenke et al.,  1990;  Disela et al.,  1991). 
How does unliganded TRot-1 arrest neuronal differentia- 
tion? First, its action seems to be independent of NGF, since 
it did not affect expression of NGF-induced early genes. It 
also failed to inhibit NGF action completely since NGF- 
treated TRo~-I-PC12 cells formed short neurites and lost ex- 
pression of the  early  neuronal marker  MASH-1.  Rather, 
TRot-1 probably causes a late block in neuronal differentia- 
tion, perhaps by repressing or limiting the expression of in- 
dispensable, neuron-specific proteins. A possible candidate 
for such proteins is N-CAM, whose expression correlates 
very well with morphological differentiation of PC12  cells 
and causes neurite formation if expressed artificially in non- 
neuronal cells (Mann et al.,  1989;  Doherty et al.,  1991). 
However, it is more likely that the observed block of  differen- 
tiation is a combined result of the insufficient expression of 
many proteins with such diverse functions as maintenance of 
neurite structure or function and regulation of cell motility 
or cell-substrate adhesion. 
The second important effect  of TRot-1 was its ability to ren- 
der differentiating PC12  cells dependent on NGF for sur- 
vival. These results may correspond to the well-known fact 
that primary neurons differentiating  in culture require neuro- 
trophic factors for survival and neurite outgrowth. By such 
a mechanism, TRa-1 could control naturally occurring neu- 
ronal death during vertebrate development where large per- 
centages (up to 80%) of certain neuronal populations un- 
dergo programmed cell death (Oppenheim,  1991). In line 
with this idea, thyroid hormone controls tissue regression 
and  neuronal  death  during  amphibian  metamorphosis 
(Kollros, 1981; Tata, 1984; Tata et al., 1991)and the survival 
of cerebellar granule cells in hypothyroid rats (Lewis et al., 
1976). 
The effects of TRo~-I and thyroid hormone were not limited 
to PC12 cells. Studies on the E 18 cell line suggest that simi- 
lar mechanisms are likely to be operating in vivo in selected 
neuronal populations of the CNS. In line with these findings 
we propose that TRo~-I controls neuronal differentiation in 
a permissive fashion: Neuronal progenitor ceils are arrested 
at a certain stage of maturation by nonliganded TRot-l, until 
they are released to differentiate when ligand becomes avail- 
able.  At this stage, neurotrophic factors like NGF are re- 
quired for survival of the differentiating cells. Thus, locally 
produced neurotrophic factors (NGF) and the systemic en- 
docrine agent T3 seem to cooperate in optimal induction of 
neuronal  differentiation  and  neuronal  gene  expression. 
Cooperation of thyroid hormone and NGF has been demon- 
strated in vivo during development of the hippocampus, ol- 
factory bulb,  and cerebellum (Clos and Legrand,  1990), 
regions which express abundantly the TRo~-I isoform of T3 
receptor (MellstrSm et al.,  1991). 
In contrast to the erythroblast system (Schroeder et al., 
1992a,b), TRa-1 does not seem to cooperate with RAPs in 
neuronal differentiation of PC12  cells since the respective 
ligand (RA) did not affect this process or its regulation by 
TRot-1.  Whether  such  a  cooperation  would  occur  upon 
artificial expression of RAPs via retrovirus vectors or in mu- 
tant PC12 cells expressing elevated RAR levels (Scheibe et 
al., 1991) remains to be determined. The RAPs might, how- 
ever,  be involved in regulating chromaffin differentiation, 
since  RA  induced morphological changes  in  PC12  cells 
resembling those induced by DEX.  If this was true,  the 
RAPs might antagonize the function of TRot-1 rather than 
cooperating with it. 
V-erbA Acts Like a Weak Constitutive Repressor of 
NGF-induced Differentiation  and Gene Expression 
In contrast to TRo~-I, the v-erbA oncoprotein caused a par- 
tial,  but  constitutive  block  of  NGF-induced  PC12  cell 
differentiation. With the exception of the transin gene, ex- 
pression of which was constitutively repressed by v-erbA, 
NGF  regulation  of other  late  genes  studied  was  hardly 
affected by v-erbA. This could be due to the fact that v-erbA 
has a lower binding affinity to regulatory sequences of target 
genes (Sap et al., 1989; Disela et al., 1991). In addition, its 
expression level in PC12 cells was perhaps not high enough 
to efficiently repress the genes studied other than transin. 
Even in avian erythroblasts (the cell type in which v-erbA 
has been selected for its oncogenic activity) a large excess 
ofv-erbA is necessary to repress genes activated by TRa-1/c- 
erbA or RAPS (Disela et al., 1991; Schroeder et al., 1992a). 
Our results suggest that v-erbA constitutively affects both 
lineages of PC12 cell differentiation. It partially arrests neu- 
ronal differentiation and gene expression, and also inhibits 
chromaffin differentiation  although it is able to constitutively 
turn on some DEX-induced genes. As a result, v-erbA gives 
rise to an aberrant "interlineage"  phenotype characterized by 
coexpression of certain neuronal and chromaffin markers 
(see Fig. 9 for a model). There are two nonexclusive possi- 
bilities  to  explain  how  v-erbA and  TRt~-l/c-erbA affect 
chromaffin differentiation and gene expression  in  such  a 
different fashion. First, the point mutations in the v-erbA 
DNA  binding  domain  might  alter  the  DNA  binding 
specificity of this mutated hormone receptor in that it now 
constitutively activates genes that are repressed by TRot-I. 
More likely, however, v-erbA differs from TRa-1/c-erbA in 
the way it interacts with other transcription factors such as 
RAPs (Sharif and Privalsky, 1991, Desbois et al., 1991) or 
members of the AP-1 transcription factor family (Zhang et 
al., 1991) in transient transcription assays using standard cell 
lines. This functional difference between v-erbA and TRot-1 
may both explain their different regulation of the chromaffin 
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on NGF-regulated proliferation of PC12 cells. Zhang et al. 
(1991)  recently  reported  that  T3-activated  c-erbA inhibits 
AP-1 activity in transiently  transfected  cells.  This may ex- 
plain  why  1"3  inhibits  cell  proliferation  in  TRtx-I-PC12 
cells.  In addition,  these  authors  showed that  a  truncated 
c-erbA carrying a COOH-terminal deletion very similar to 
that present in v-erbA  was unable to block AP-1 activity,  per- 
haps explaining why proliferation of our v-erbA-PC12 cells 
was not affected by T3 (Fig. 4 A). 
TRa-l-dependent Regulation of PC12 Differentiation: 
Relevance for Neuronal Differentiation in the CNS 
Our results have several immediate consequences for the un- 
derstanding  of how thyroid hormone might act in the CNS. 
The observed permissive action of TRc~-I on neuron matura- 
tion could be an underlying mechanism for the abnormalities 
occurring in the hypothyroid  rat brain.  Unliganded TRc~-I 
might cause a late block in neurotrophin-dependent  neuronal 
maturation.  Similarly, the observation that the lesions can be 
reverted  by  T3  administration  during  a  critical  period 
(Legrand,  1984)  agrees well with the fact that T3 releases 
the cells from this late block. By using the PC12 cell line ap- 
proach, we were able to identify a good-sized number of can- 
didate  genes  for regulation  by  T3  and  its  receptor.  Such 
genes may be impossible to detect by eDNA library screen- 
ing approaches employing the whole brain or parts of it (Mu- 
fioz et al., 1991),  since they may only occur in selected neu- 
ronal  cell populations  or during  specific  phases  of brain 
development. 
Although this work strongly suggests a direct, important 
role of thyroid hormone receptors in brain development, we 
are ignorant about mechanisms  governing TR expression, 
the ratios  between the different  TR types,  and the (likely) 
functional  differences  between  the  different  TRs.  Thus, 
studies like those presented here will have to be extended to 
other, preferably brain-derived neural cell types, to other TR 
types,  and  to  the  other  neurotrophic  factors  recently 
identified (Barde et al.,  1982; Leibrock et al.,  1989;  Lin et 
al.,  1989;  Hohn et al.,  1990;  Jones and Reichardt,  1990; 
Maisonpierre et al.,  1990;  Berkemeier et al.,  1991;  Hall- 
b66k et al., 1991).  An obvious choice for such systems will 
be neuroblast lines such as the E 18 line described here. Due 
to the instability of such lines and their reported  ability to 
change their phenotype (e.g., from neuronal to glial, Gage, 
1992), more work is required before such lines can be used 
for molecular studies in the fashion described here for the 
PC12 system. 
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